Howard W Robin, Director, President & Chief Executive Officer, on June 16, 2026, sold 20,000 shares in Nektar Therapeutics (NKTR) for $1,215,056. Following the Form 4 filing with the SEC, Robin has control over a total of 55,073 common shares of the company, with 55,045 shares held directly and 28 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/906709/000119312526276236/xslF345X05/ownership.xml